drugset / Trial / NCT06761092

Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

NCT06761092 ↗

Phase 4 Active not recruiting 72 enrolled Udayana University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Analyzing the effectiveness of nebulized dexmedetomidine 2 mcg/kg in reducing the incidence of post-anesthesia delirium in preschool children undergoing elective surgery with sevoflurane inhalation general anesthesia. Researchers will compare nebulized Dexmedetomidine to a placebo (a look-alike substance that contains no drug) to see if the drug can reduce post anesthesia delirium incidence.

Timeline

Start
2024-12-13
Primary completion
2025-02-07
Completion
2025-02-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 2 ug/kg Other

Indications